文献速递肾血管病与高血压水电解质与酸碱遗传性与小管间质肾病

组成性激活的SPAK通过激活NCC和重塑远端小管导致高钾血症

Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
PubMed 文献 · J Am Soc Nephrol · 2017-04-25

本研究在小鼠早期远曲小管特异性表达组成性激活的SPAK突变体,发现其导致噻嗪类可治疗的高血压和高钾血症,伴NCC过度磷酸化。噻嗪类抑制NCC恢复排钠后并未立即恢复尿钾排泄,而阻断NCC可逐渐恢复醛固酮敏感远端肾单位结构及ENaC和ROMK表达,同时恢复尿钾排泄。结果证实NCC过度活化是家族性高钾性高血压的基础,但高钾血症还涉及DCT-ASDN偶联过程异常。

要点

  • CA-SPAK小鼠出现噻嗪类可治疗的高血压和高钾血症,伴NCC过度磷酸化。
  • 噻嗪类抑制NCC恢复排钠后未立即恢复尿钾排泄,提示高钾血症另有机制。
  • CA-SPAK小鼠存在ASDN重塑,包括连接小管质量减少及ENaC和ROMK表达与顶膜定位减弱。

核心结论

  • NCC过度活化是FHHt的基础,但NCC依赖的钾分泌驱动力改变不足以解释高钾血症。
  • DCT-ASDN偶联过程调控钾平衡,在FHHt中异常激活。

研究设计与样本

  • 在小鼠Stk39基因Lox-P位点后引入激酶激活突变,利用DCT驱动的Cre重组酶在早期DCT特异性表达CA-SPAK突变体。

主要发现

  • CA-SPAK小鼠表现为噻嗪类可治疗的高血压和高钾血症,伴NCC过度磷酸化。
  • 噻嗪类介导的NCC抑制及排钠恢复未立即恢复CA-SPAK小鼠的尿钾排泄。
  • CA-SPAK小鼠出现ASDN重塑:连接小管质量减少,ENaC和ROMK表达及顶膜定位减弱。
  • 阻断DCT中过度活跃的NCC可逐渐恢复ASDN结构、ENaC和ROMK表达,并恢复尿钾排泄。

临床怎么用

  • 噻嗪类可治疗CA-SPAK相关高血压,但高钾血症的纠正可能滞后于排钠恢复。
  • FHHt高钾血症的管理需关注ASDN重塑及ENaC/ROMK功能恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aberrant activation of with no lysine (WNK) kinases causes familial hyperkalemic hypertension (FHHt). Thiazide diuretics treat the disease, fostering the view that hyperactivation of the thiazide-sensitive sodium-chloride cotransporter (NCC) in the distal convoluted tubule (DCT) is solely responsible. However, aberrant signaling in the aldosterone-sensitive distal nephron (ASDN) and inhibition of the potassium-excretory renal outer medullary potassium (ROMK) channel have also been implicated. To test these ideas, we introduced kinase-activating mutations after Lox-P sites in the mouse Stk39 gene, which encodes the terminal kinase in the WNK signaling pathway, Ste20-related proline-alanine-rich kinase (SPAK). Renal expression of the constitutively active (CA)-SPAK mutant was specifically targeted to the early DCT using a DCT-driven Cre recombinase. CA-SPAK mice displayed thiazide-treatable hypertension and hyperkalemia, concurrent with NCC hyperphosphorylation. However, thiazide-mediated inhibition of NCC and consequent restoration of sodium excretion did not immediately restore urinary potassium excretion in CA-SPAK mice. Notably, CA-SPAK mice exhibited ASDN remodeling, involving a reduction in connecting tubule mass and attenuation of epithelial sodium channel (ENaC) and ROMK expression and apical localization. Blocking hyperactive NCC in the DCT gradually restored ASDN structure and ENaC and ROMK expression, concurrent with the restoration of urinary potassium excretion. These findings verify that NCC hyperactivity underlies FHHt but also reveal that NCC-dependent changes in the driving force for potassium secretion are not sufficient to explain hyperkalemia. Instead, a DCT-ASDN coupling process controls potassium balance in health and becomes aberrantly activated in FHHt.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Grimm PR, Coleman R, Delpire E, et al. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules. J Am Soc Nephrol. 2017. PMID: 28442491. doi:10.1681/ASN.2016090948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。